Karyopharm Therapeutics
KPTI
KPTI
117 hedge funds and large institutions have $64.2M invested in Karyopharm Therapeutics in 2023 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 25 increasing their positions, 41 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
38% less capital invested
Capital invested by funds: $103M → $64.2M (-$38.6M)
39% less repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 41
Holders
117
Holding in Top 10
–
Calls
$456K
Puts
$26K
Top Buyers
| 1 | +$1.53M | |
| 2 | +$1.44M | |
| 3 | +$1.1M | |
| 4 |
Renaissance Technologies
New York
|
+$1.07M |
| 5 |
Morgan Stanley
New York
|
+$559K |
Top Sellers
| 1 | -$2.38M | |
| 2 | -$1.87M | |
| 3 | -$1.79M | |
| 4 |
BlackRock
New York
|
-$878K |
| 5 |
PL
Parkwood LLC
Cleveland,
Ohio
|
-$661K |